Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Shehnaaz Suliman currently holds 37,445 shares of Theravance Biopharma, Inc. (TBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Shehnaaz Suliman has been a net seller of TBPH stock. They have purchased $0 and sold $6.8M worth of shares.
Shehnaaz Suliman's most recent insider trade was on Jun 4, 2026, when they sold 8,829 shares at $0.00 per share.
Shehnaaz Suliman serves as Executive at Theravance Biopharma, Inc. (TBPH). They have executed 34 insider transactions totaling $6.8M over their tenure at the company.
Shehnaaz Suliman holds the position of Executive at Theravance Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Shehnaaz Suliman has shown a selling trading pattern, with $0 in total purchases and $6.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Shehnaaz Suliman was on Dec 9, 2021, when they sold $1.6M worth of ALEC shares. This transaction involved 72,357 shares at $22.80 per share.
Shehnaaz Suliman currently owns 37,445 shares of Theravance Biopharma, Inc. (TBPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Shehnaaz Suliman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Shehnaaz Suliman has 34 Form 4 filings on record as an insider at Theravance Biopharma, Inc..
Set alerts for Shehnaaz Suliman and 40,000+ other insiders.